GASC1 inhibitor caffeic acid
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GASC1 inhibitor caffeic acid, covering 2020-12-03 to 2020-12-03. Get the full timeline:
Most recent: Clinical Trial Update: GASC1 Inhibitor Caffeic Acid for Squamous Esophageal Cell Cancer (ESCC) [Phase 3]